Standard Chemical & Pharmaceutical Co Ltd (1720) — Capital Reinvestment Ratio
Standard Chemical & Pharmaceutical Co Ltd (1720) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$510.55 Million) in capital expenditures (NT$78.71 Million). See 1720 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Standard Chemical & Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2024)
This chart tracks Standard Chemical & Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods.
Annual Capital Reinvestment Ratio for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
Year-by-year Capital Reinvestment Ratio for Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. For live market cap and broader valuation context, see 1720 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | NT$1.69 Billion | NT$599.61 Million | ▼ -24.4% |
| 2023 | 0.47x | NT$1.34 Billion | NT$625.70 Million | ▼ -52.0% |
| 2022 | 0.98x | NT$1.23 Billion | NT$1.20 Billion | ▲ +270.2% |
| 2021 | 0.26x | NT$827.03 Million | NT$217.92 Million | ▼ -31.0% |
| 2020 | 0.38x | NT$922.58 Million | NT$352.49 Million | ▲ +36.1% |
| 2019 | 0.28x | NT$637.94 Million | NT$179.11 Million | ▼ -19.6% |
| 2018 | 0.35x | NT$484.94 Million | NT$169.36 Million | ▼ -35.8% |
| 2017 | 0.54x | NT$708.74 Million | NT$385.64 Million | ▼ -6.6% |
| 2016 | 0.58x | NT$305.38 Million | NT$177.92 Million | ▲ +111.9% |
| 2015 | 0.27x | NT$650.87 Million | NT$178.98 Million | ▼ -9.8% |
| 2014 | 0.30x | NT$582.30 Million | NT$177.53 Million | ▼ -69.2% |
| 2013 | 0.99x | NT$427.26 Million | NT$422.73 Million | ▲ +61.3% |
| 2012 | 0.61x | NT$402.25 Million | NT$246.76 Million | ▼ -16.7% |
| 2011 | 0.74x | NT$405.49 Million | NT$298.50 Million | ▼ -35.2% |
| 2010 | 1.14x | NT$272.47 Million | NT$309.66 Million | ▲ +170.8% |
| 2009 | 0.42x | NT$634.23 Million | NT$266.14 Million | ▲ +56.8% |
| 2008 | 0.27x | NT$719.17 Million | NT$192.50 Million | ▲ +19.1% |
| 2007 | 0.22x | NT$323.60 Million | NT$72.72 Million | ▼ -15.1% |
| 2006 | 0.26x | NT$358.75 Million | NT$95.01 Million | ▲ +93.4% |
| 2005 | 0.14x | NT$370.77 Million | NT$50.78 Million | ▲ +12.2% |
| 2004 | 0.12x | NT$335.45 Million | NT$40.95 Million | ▼ -77.8% |
| 2003 | 0.55x | NT$272.89 Million | NT$149.81 Million | ▼ -57.9% |
| 2002 | 1.30x | NT$147.75 Million | NT$192.54 Million | — |